Massive Interactive is a leading provider of software and design services for content distribution, helping media owners and distributors build, grow and engage a wider audience on multiple platforms. Massive specializes in building innovative and proven TV solutions across consumer devices, economically and efficiently for a range of clients including Media owners, Telcos, Airlines and content distributors worldwide. Massive s product suite includes the award winning MDK, Multi Screen Development Kit, A one of a kind TV everywhere solution that provides a truly scalable and quick to market multiscreen solution allowing for an efficient and speedy deployment of apps across the increasingly fragmented device landscape. Our clients include Viacom s Channel , YouView, Deutsche Telekom, the BBC, British Telecom, Rogers, Bell Media, Freeview, Nine Network, Telstra, Foxtel, Emirates, Virgin Atlantic, Qantas, Singapore Airlines among others. Specialties Leading provider of multiscreen digital software, Scalable and quick to market Multiscreen content delivery, Customizable Multiplatorm VOD Storefront, Off the shelf as well as bespoke UI design solutions, End to end hosted video, Design Consultancy
Quote | FSD Pharma Inc. (OTCMKTS:HUGE)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $0.2265 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | FSD Pharma Inc. (OTCMKTS:HUGE)
TORONTO, ON / ACCESSWIRE / May 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma "), provides an update by way of a news release issued by Celly Nutrition Corp. (" Celly Nu "), its new packaging and logo of unbuzzd™ expected to launch this summer, an innovative be...
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...
Message Board Posts | FSD Pharma Inc. (OTCMKTS:HUGE)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $HUGE News Article - FSD Pharma Announces Its Australian Entity Receives Approval to Pr | whytestocks | investorshangout | 03/22/2023 3:20:47 PM |
whytestocks: $HUGE News Article - FSD Pharma (Symbol: HUGE) Renews Shareholder Intelligence Services | whytestocks | investorshangout | 03/14/2023 7:50:48 PM |
whytestocks: $HUGE News Article - Original "Shark" and Iconic Entrepreneur Kevin Harrington Joins FS | whytestocks | investorshangout | 02/28/2023 3:55:49 PM |
whytestocks: $HUGE News Article - FSD Pharma Presenting Two Scientific Posters on Preclinical Toxico | whytestocks | investorshangout | 02/21/2023 4:05:47 PM |
whytestocks: $HUGE News Article - InvestmentPitch Media Video Discusses FSD Pharma's Receipt of No O | whytestocks | investorshangout | 02/09/2023 5:25:45 PM |
News, Short Squeeze, Breakout and More Instantly...
FSD Pharma Inc. Company Name:
HUGE Stock Symbol:
OTCMKTS Market:
TORONTO, ON / ACCESSWIRE / May 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma "), provides an update by way of a news release issued by Celly Nutrition Corp. (" Celly Nu "), its new packaging and logo of unbuzzd™ expected to launch this summer, an innovative be...
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announces the submission to ethics of a trial. Entitled “A Phase 1, Randomize...